For accelerated healthcare performance, jump into the data lakehouse
Learn how a data lakehouse optimizes business intelligence and outcomes in healthcare.
For accelerated healthcare performance, jump into the data lakehouse Read More »
Uncategorized
Increase customer satisfaction with accurate person data
Why health tech leaders must prioritize Enterprise Master Person Index technology for their products.
Increase customer satisfaction with accurate person data Read More »
¿Cómo funciona la fotosíntesis?
La fotosíntesis es uno de los procesos más asombrosos y fundamentales en la Tierra, responsable de la producción de oxígeno y la captura de energía solar para alimentar la vida en nuestro planeta. ¿Qué es la fotosíntesis? La fotos&iacu …
El Teorema de la Equipartición de la Energía
El Teorema de la Equipartición de la Energía es una piedra angular en el edificio conceptual de la física moderna. Este principio, derivado de la mecánica estadística, revela cómo la energía se distribuye entre las diferentes formas de movimiento y al …
Todo lo que necesitas saber sobre los abortos espontáneos
Los abortos espontáneos, también conocidos como pérdidas gestacionales, son eventos trágicos que afectan a muchas parejas en todo el mundo. Aunque pueden ser devastadores emocionalmente, entender las causas subyacentes, los síntomas y las opciones de tratamiento es …
Todo lo que necesitas saber sobre los abortos espontáneos Read More »
Labcorp Presents New Research Demonstrating Clinical Impact of Precision Diagnostics in Guiding Biomarker-targeted Therapies for Patients with Epithelial Ovarian Cancer
Labcorp, a global leader of innovative and comprehensive laboratory services, presented the results from two studies at the 2024 SGO Annual Meeting on Women’s Cancer.
Positive RUBY phase III data show potential for Jemperli (dostarlimab-gxly) combinations in more patients with primary advanced or recurrent endometrial cancer
GSK plc announced statistically significant and clinically meaningful overall survival results from Part 1 and progression-free survival results from Part 2 of the RUBY/ENGOT-EN6/GOG3031/NSGO phase III trial in adult patients with primary advanced or recurrent endometrial cancer.
ProSomnus Reschedules Fourth Quarter and Fiscal Year 2023 Investor and Business Update Call
ProSomnus, Inc. announced it has postponed the release of its 2023 fourth quarter and full year financial results and the related investor conference call.
Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand
Fennec Pharmaceuticals Inc. and Norgine announced an exclusive licensing agreement under which Norgine will commercialize PEDMARQSI® in Europe, Australia and New Zealand.
Strong Fourth Quarter Powers 2023 Kelyniam Financials
Kelyniam Global, a maker of custom cranial implants, announced results for its year ended December 31, 2023.
Strong Fourth Quarter Powers 2023 Kelyniam Financials Read More »